All stacksWeight Loss stack

The Skin Saver

Lose the weight, keep the skin tight. Three tiers, from R2 520, each listed with what is in it, why the compounds are combined, and who should not use it.

05

The Skin Saver

Lose the weight, keep the skin tight

Safe
Weight LossPhased — 3+ Months

Month 1 to 2 (fat loss phase): GLP-1 agonist drives significant fat reduction, with AOD-9604 enhancing lipolysis at the cellular level. Month 3 onwards (skin phase): GHK-Cu triggers collagen synthesis and dermal remodelling to address loose skin from rapid fat loss. AHK-Cu adds scalp and follicle recovery, while BPC-157 repairs the connective tissue layer beneath.

TierIncludesPrice

Tap a tier to choose it

Safety Note

One of the strongest stacks from a safety standpoint. GLP-1 and skin peptide mechanisms operate in completely separate biological pathways, and the phased structure ensures no interaction. All skin-phase components carry excellent safety profiles.

Contraindications — Do Not Use If:

Wilson's disease or copper metabolism disorders. GHK-Cu and AHK-Cu are contraindicated.

Personal or family history of medullary thyroid carcinoma or MEN syndrome.

History of pancreatitis.

Pregnancy and breastfeeding.

Under 18 years of age.

Pregnancy and breastfeeding. None of the stacks in this guide have been evaluated for safety during pregnancy.

Under 18 years of age. Not suitable for minors.

Active cancer or personal history of cancer. Consult an oncologist before using any GH-stimulating, telomerase-activating, or immune-modulating peptides.

Type 1 or Type 2 diabetes on medication. GH secretagogues and GLP-1 agonists affect blood glucose; medical supervision is required.

Immunosuppressant medications. Thymosin Alpha-1, Thymalin, and Epithalon actively stimulate immune function and may counteract immunosuppressive therapy.

Wilson's disease or copper metabolism disorders. GHK-Cu and AHK-Cu are contraindicated.

Medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome. GLP-1 receptor agonists are contraindicated.

History of pancreatitis. GLP-1 receptor agonists carry a risk of pancreatitis.

Athletes subject to WADA anti-doping testing. TB-500, GH secretagogues, and HGH Somatropin are all prohibited substances.

All peptides on this page are for research purposes only and are not intended for human or veterinary use.

All products are for research purposes only and are not intended for human or veterinary use.